Sen-Age

Biomarker1 paper2 findings

  • Humans1

Upstream

1

Cancer

upin humans1

1 study
  1. Cancer increases Sen-Age in humans (adj mean: -0.44 vs -0.83).

    “Moreover, cancer survivors have higher Sen-Age score (adj mean: -0.44 ) than non-cancer controls (adj mean: -0.83).”

    Humanscancer survivors compared to non-cancer controlsblood

    SenMayo Based Aging Signature (Sen-Age) in cancer survivors: The Health and Retirement Study (HRS) · GSA 2025 abstract · 31 Dec 2025

Cancer →

Associations

1

Mortality

upin humans1HR 1.47

1 study
  1. Sen-Age is associated with mortality in humans (HR: 1.47 [1.17–1.85] per 1 year).

    “Sen-Age was associated with increased risk of mortality in cancer survivors (HR: 1.47 [1.17–1.85] per 1 year, p = 0.0008).”

    Humansin cancer survivors, adjusted for age, sex, and raceblood4-yearn = 609

    SenMayo Based Aging Signature (Sen-Age) in cancer survivors: The Health and Retirement Study (HRS) · GSA 2025 abstract · 31 Dec 2025

Latest

Nov 2025: 0Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01